Skip to contentpdufa.bio

CT1812

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

CT1812 is a Cognition Therapeutics Inc program. Its next catalyst is a Readout in May 2027.

CGTX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Cognition Therapeutics Inc (CGTX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · May 2027CGTX

Questions

When is CT1812's next FDA decision or readout?

The next tracked catalyst for CT1812 is a Readout in May 2027.

What happened at CT1812's most recent FDA decision?

No FDA decision for CT1812 is in our archive yet.

Who makes CT1812?

Cognition Therapeutics Inc (CGTX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.